• ENGLISH
  • FRANCAIS
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blogs
    • Case Studies
    • Podcasts
    • Webinars
    • White Papers
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Program
  • Contact Us
    • Contact Us
    • Request for Proposal
  • ENGLISH
  • FRANCAIS
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blogs
    • Case Studies
    • Podcasts
    • Webinars
    • White Papers
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Program
  • Contact Us
    • Contact Us
    • Request for Proposal
  1. Home
  2. Services
  3. Clinical Trial Operations
  4. Clinical Operations
    • Protocol Development and Study Design
    • Feasibility and Study Start Up
    • Patient Recruitment
    • Project Management
    • Clinical Operations
    • Centralized Monitoring
    • Decentralized Clinical Trials (DCT)
    • Centralized eTMF
    • Medical Services

Clinical Operations

  • Clinical Trial Operations
  • Protocol Development and Study Design
  • Feasibility and Study Start Up
  • Patient Recruitment
  • Project Management
  • Clinical Operations
  • Centralized Monitoring
  • Decentralized Clinical Trials (DCT)
  • Centralized eTMF
  • Medical Services
    • Medical Monitoring
    • Pharmacovigilance and Patient Safety
    • Therapeutic Oversight

Allucent is focused on helping small and mid-size biotech sponsors navigate the clinical trial process from strategy to approval, aiming to bring your breakthrough ideas to patients awaiting them. With more than 30 years of worldwide experience in trial design and execution, complex therapeutic areas, and challenging indications, we are ready to join you as a valuable partner and trusted extension of your team’s capabilities.

Building relationships with your partners – physicians, investigators, hospital personnel – is fundamental to the effective conduct of your clinical trials. This is the primary responsibility of the clinical research associate (CRA), who works on the front lines of your study as protocol and project manager. 

Highly experienced personnel are essential for this role, as they are responsible for key elements of clinical operations. This encompasses regulatory approval to commence the trial, site selection, training on study protocol, and supporting and overseeing site performance and safety throughout the project. The CRA oversees patient recruitment, compliance with patient profile and protocol, and quality-driven assessment to ensure that the expectations of both the sponsor and regulators are met.

Allucent CRAs work side by side with your team, lending deep knowledge gained through extensive collaboration with small and mid-sized biotech companies on countless projects. Our CRA team comprises the A-team: physicians and PhD scientists extending across the EU, including Eastern Europe, North America, and Latin America, with an additional hub covering India and Africa. Our global footprint enables us to support you through later phases, and to observe regional differences, detect trends across multiple sites, and take proactive steps to mitigate potential risks in data quality. 

Each trial benefits from a CRA with experience in the relevant therapeutic area. The CRA understands the practicalities of executing the study in the clinic as well as the challenges of the project team and sponsor – a perspective that supports pragmatic protocol design. Our flexible, adaptable approach is especially important for small and mid-size biotechs that occasionally encounter business adjustments or changing priorities during the course of the study.

Contact Us

Let us partner with your team on bringing new therapies to light. Get in touch to get started.

CONTACT US

  • Services
    • Clinical Trial Operations
    • Regulatory and Drug Development Consulting
    • Government and Public Health Services
    • Biometrics
    • Clinical Pharmacology Modeling Simulation
  • Therapeutic Expertise
    • Oncology and Hematology
    • Rare Diseases and Orphan Drugs
    • Infectious Disease and Vaccine
    • Cell and Gene Therapy
    • Central Nervous System
    • Autoimmune and Inflammation
    • Allergy and Asthma
  • Company
    • About Us
    • News
    • Events
  • Privacy Policy
  • English
  • Francais

© 2023 Allucent. All rights

North American Headquarters
2000 Centregreen Way
Suite 300
Cary, North Carolina 27513
+1 919-361-2286

United Kingdom Headquarters
1st Floor, One Station Square,
Bracknell, Berkshire
RG12 1QB United Kingdom
T: +44 (0) 1344 891121
F: +44 (0) 1344 890335

European Headquarters
Stationsplein Noord-Oost 438
1117 CL Schiphol
The Netherlands
+31 20-4350-580